SCHEMBL14138169

SCHEMBL14138169

CC[C@H]1C(O)CC=C2C(=O)OCC[C@H]21

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ STAT3 P40763 1/20 0.31
▸ NR1H4 Q96RI1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9181141 0.69 BCL2L1 (0.35) —
SCHEMBL2319141 0.59 BACE1 (0.32) —
SCHEMBL14010720 0.58 STAT3 (0.40) STAT3
SCHEMBL27878847 0.57 CYP1A2 (0.40) MAPT
SCHEMBL29425826 0.56 — —
SCHEMBL30430603 0.56 CHRNB2 (0.35) —
SCHEMBL31371996 0.56 STAT3 (0.56) STAT3
SCHEMBL13970949 0.55 — —
SCHEMBL8394029 0.55 CYP1A2 (0.33) —
SCHEMBL19310746 0.54 MAPT (0.34) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008100547-A2 COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B NY FINANCIAL (INTERNATIONAL) CORPORATION (VG) 2008-08-21 — — WO disclosed
Send feedback